Channabasavaiah Gurumurthy, BVSC, MVSC, PhD, EMBA, Director, Mouse Genome Engineering Core Facility, Professor of Genetics, Cell Biology and Anatomy at the University of Nebraska Medical Center. Dr. Gurumurthy has published dozens of CRISPR technology papers and developed a better version of CRISPR called Easi-CRISPR.
In December 2023, the U.S. Food and Drug Administrations (FDA) announced approval of a milestone treatment for sickle cell disease:…
